此应用程序的某些内容目前无法使用。
如果这种情况持续存在,请联系我们反馈与联系
1. (US20140329908) Method for the treatment of dravet syndrome
注:相关文本通过自动光符识别流程生成。凡涉及法律问题,请以 PDF 版本为准

Claims

1. A method of ameliorating seizures in a patient diagnosed with Dravet syndrome, comprising:
orally administering an effective dose of fenfluramine or a pharmaceutically acceptable salt thereof;
orally administering an effective dose of stiripentol or a pharmaceutically acceptable salt thereof to said patient;
orally administering an effective dose of valproate or a pharmaceutically acceptable salt thereof to said patient; and
orally administering an effective dose of clobazam or a pharmaceutically acceptable salt thereof to said patient,
whereby seizures are ameliorated in the patient.
2. The method of claim 1, wherein the fenfluramine or pharmaceutically acceptable salt thereof is administered in a dose of 0.5 mg/kg/day to 0.01 mg/kg/day to the patient.
3. A method of ameliorating seizures in a patient diagnosed with Dravet syndrome, comprising:
orally administering a liquid formulation comprised of an effective dose of fenfluramine or a pharmaceutically acceptable salt thereof;
orally administering an effective dose of stiripentol or a pharmaceutically acceptable salt thereof to said patient;
orally administering an effective dose of valproate or a pharmaceutically acceptable salt thereof to said patient; and
orally administering an effective dose of clobazam or a pharmaceutically acceptable salt thereof to said patient,
wherein the fenfluramine or pharmaceutically acceptable salt thereof is administered in a dose of 0.5 mg/kg/day to 0.01 mg/kg/day to the patient,
whereby seizures are ameliorated in the patient.